SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases

被引：1

作者：

Maggioni, Aldo P. ^{[1
]}

机构：

[1] ANMCO Res Ctr, I-50121 Florence, Italy

来源：

PHYSICIAN AND SPORTSMEDICINE | 2009年 / 37卷 / 03期

关键词：

sibutramine; randomized trial; cardiovascular outcomes; weight loss; obesity;

D O I：

10.3810/psm.2009.10.1734

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Practice Pearl: These preliminary data from the SCOUT trial appear to demonstrate that sibutramine is well tolerated by high-risk cardiovascular patients. Original Article: Torp-Pedersen C, Caterson I, Coutinho W, et al; SCOUT Investigators. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J. 2007;28(23):2915-2923.

引用

页码：95 / 97

页数：3

共 6 条

[1]

[Anonymous], INT OBESITY TASKFORC

[2] Meta-analysis: The effect of dietary counseling for weight loss [J].